Subject of the day
RTW.L
RTW Biotech Opportunities Ltd is a venture capital fund. The fund specializes in directly investing and early-stage. The fund specializes in identifying transformative assets with high growth potential across the life sciences, biopharmaceutical and medical technology sectors. The fund invests in companies developing next-generation therapies and technologies that can significantly improve patients' lives.
$2.61
▲ +0.08 (+3.2%)
| 52w hi | $2.61 |
|---|---|
| 52w lo | $1.40 |
| Vol | 640.41K |
| As of | Aug 13 |
Our score +0.66
| Short | +0.84 |
|---|---|
| Medium | +0.63 |
| Long | +0.39 |
computed 2026-08-13
RTW Biotech Opportunities Ltd
Financial Services · Asset Management
| Market cap | $841.52M |
|---|---|
| Enterprise value | $897.14M |
| Trailing P/E | 4.14x |
| Forward P/E | — |
| EV / EBITDA | — |
| P / S (ttm) | 24.34x |
| Profit margin | 709.2% |
| Return on equity | 32.7% |
| Revenue growth | -10.0% |
| Earnings growth | — |
| Debt / equity | — |
| Beta vs SPX | 0.06 |
|---|---|
| Corr SPX | 0.04 |
| Annual vol | 22.7% |
| Annual ret | +30.0% |
| Sharpe | 1.32 |
| Max DD | -29.4% |
Window: 504 trading days (491 obs)
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | +0.26 | |
| Sector | +0.09 | |
| Technical | +0.29 | |
| Earnings | +0.00 | |
| Sentiment | +0.55 |
macro × 1.00 · 2026-08-13
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Aug 13 | $2.58 | $2.61 | $2.55 | $2.61 | 640.41K |
| Aug 12 | $2.55 | $2.59 | $2.51 | $2.53 | 284.42K |
| Aug 11 | $2.50 | $2.58 | $2.45 | $2.57 | 402.64K |
| Aug 10 | $2.52 | $2.52 | $2.50 | $2.51 | 65.92K |
| Aug 7 | $2.50 | $2.52 | $2.45 | $2.51 | 330.33K |